When barriers fail: the role of endothelial dysfunction in rare pediatric neuromuscular diseases - Takeaways - MDSpire

Endothelial Dysfunction's Impact on Rare Neuromuscular Disorders in Pediatrics: Understanding Barrier Failures

  • By

  • Aleksandra Agafonova

  • Alessia Cosentino

  • Chiara Prinzi

  • Claudia Parano

  • Angela Trovato Salinaro

  • Maria Concetta Scuto

  • Giordana Riccioli

  • Gabriella Lupo

  • Carmelina Daniela Anfuso

  • July 20, 2026

Share

  • 1

    Endothelial dysfunction and blood-tissue barrier alterations contribute to the onset and progression of rare pediatric neuromuscular diseases.

  • 2

    The blood-brain barrier (BBB) and blood-nerve barrier (BNB) are crucial for regulating molecular exchange and maintaining neural homeostasis.

  • 3

    Duchenne muscular dystrophy, spinal muscular atrophy, and other rare conditions show that vascular and barrier abnormalities influence disease severity.

  • 4

    The BNB is structurally more restrictive than the BBB, impacting drug delivery and contributing to the development of peripheral neuropathies.

  • 5

    Understanding endothelial dysfunction's role in neuromuscular diseases may provide insights into potential diagnostic and therapeutic targets.

Original Source(s)

When barriers fail: the role of endothelial dysfunction in rare pediatric neuromuscular diseases

  • by Aleksandra Agafonova, Alessia Cosentino, Chiara Prinzi, Claudia Parano, Angela Trovato Salinaro, Maria Concetta Scuto, Giordana Riccioli, Gabriella Lupo, Carmelina Daniela Anfuso

  • July 20, 2026

Related Content

Treatable Pediatric Neuromuscular Disorders

Through a case-based, evidence-driven approach, this Neuroscience Grand Rounds session highlights how clinicians can differentiate among neuromuscular conditions, localize disease processes and identify those disorders where timely treatment can significantly alter disease trajectory.

  • June 19, 2026

  • 1 min
New Label Expansion in Generalized Myasthenia Gravis

Phase 3 ADAPT SERON data supported efgartigimod use across antibody subtypes often underrepresented in trials.

Misdiagnosis Common in Parkinsonian Disorders

Autopsy-confirmed findings linked diagnostic errors, co-pathology, and genetic variation to distinct pathologic patterns across more than 3,300 donors with Parkinsonian disorders.